Barbara Riboli

Title: Barbara Riboli: Innovator in Genetic Research

Introduction

Barbara Riboli is a prominent inventor based in Cremona, Italy, known for her significant contributions to genetic research. With a total of three patents to her name, she has made remarkable strides in the field of molecular biology, particularly in the development of vaccines.

Latest Patents

Her latest patents include groundbreaking work on the cloning and sequencing of genes that code for new pilinic subunits. One notable patent describes the cloning and sequencing of the gene which codes for a new pilinic subunit of Bordetella pertussis. The amino acid sequence of the mature subunit, deduced from its nucleotide sequence, shows similarities to known pilins 2, 3, and 6, making it particularly useful for developing synthetic acellular vaccines against pertussis. Another patent focuses on the cloning of the gene that codes for the pilinic subunit fim3 of Bordetella pertussis. This patent includes a cloned DNA fragment, vectors containing it, and microorganisms transformed by these vectors. The protein and peptides corresponding to at least one epitope of the gene are also valuable for the development of acellular anti-pertussis vaccines.

Career Highlights

Barbara has worked with notable companies such as Eniricerche S.p.a. and Eniricerche S.p.a. Her work has significantly impacted the field of vaccine development, particularly in combating pertussis.

Collaborations

Throughout her career, Barbara has collaborated with esteemed colleagues, including Paola Pedroni and Guido Grandi. These partnerships have further enhanced her research and contributions to genetic science.

Conclusion

Barbara Riboli's innovative work in genetic research and vaccine development has established her as a key figure in her field. Her patents reflect her dedication to advancing medical science and improving public health.